Paratek Pharmaceuticals, Inc. (PRTK) Social Stream
PARATEK PHARMACEUTICALS INC (PRTK) Price Targets From Analysts
Use the tables below to see what analysts covering PARATEK PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
PRTK's average price target has moved down $1.13 over the prior 35 months.
PRTK reports an average of 783.96% for its upside potential over the past 49 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PRTK Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
PRTK's average broker recommendation rating improved by 0 over the prior 43 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, PARATEK PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 1439.47% of them.
- In the context of all US stocks, PARATEK PHARMACEUTICALS INC's number of analysts covering the stock is higher than 90.07% of them.
- In the context of stocks in the small market cap category, PARATEK PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1166.41% of them.
- PARATEK PHARMACEUTICALS INC's average analyst price target is higher than 486.89% of Healthcare stocks.
Stocks similar to PARATEK PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VBIV, ATNF, and ATNX.
View All Top Stocks by Price Target
Make investment decisions regarding PRTK using the data that counts. Try POWR Ratings for free.